{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:25:57Z","timestamp":1790357157692,"version":"4.1.0"},"reference-count":45,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4740","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T08:11:46Z","timestamp":1551773506000},"source":"Crossref","is-referenced-by-count":4,"title":["TOPK is regulated by PP2A and BCR\/ABL in leukemia and enhances cell proliferation"],"prefix":"10.3892","author":[{"given":"Emi","family":"Uchida","sequence":"first","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihoko","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoto","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kasama","sequence":"additional","affiliation":[{"name":"Research Center for Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tokyo Medical and Dental University, Tokyo 113\u20118519, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"key20200713185736_b1-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"key20200713185736_b2-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.beha.2016.10.005","article-title":"Management of CML-blast crisis","volume":"29","author":"Hehlmann","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20200713185736_b3-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/febs.14617","article-title":"Targeted therapies don\u2019t work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back","volume":"285","author":"Westermarck","year":"2018","journal-title":"FEBS J"},{"key":"key20200713185736_b4-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2005.10.015","article-title":"The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein","volume":"8","author":"Neviani","year":"2005","journal-title":"Cancer Cell"},{"key":"key20200713185736_b5-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00561-4","article-title":"Role of serine\/threonine protein phosphatase 2A in cancer","volume":"170","author":"Sch\u00f6nthal","year":"2001","journal-title":"Cancer Lett"},{"key":"key20200713185736_b6-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.coi.2004.07.015","article-title":"HLA class I antigen expression in malignant cells: Why does it not always correlate with CTL-mediated lysis?","volume":"16","author":"Chang","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"key20200713185736_b7-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbrc.2004.10.133","article-title":"Characterization of a MAPKK-like protein kinase TOPK","volume":"325","author":"Matsumoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713185736_b8-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1073\/pnas.090102397","article-title":"Characterization of PDZ-binding kinase, a mitotic kinase","volume":"97","author":"Gaudet","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185736_b9-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bcmd.2003.10.004","article-title":"Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells","volume":"32","author":"Nandi","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"key20200713185736_b10-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1349-7006.2011.02197.x","article-title":"Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma","volume":"103","author":"Wei","year":"2012","journal-title":"Cancer Sci"},{"key":"key20200713185736_b11-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.21873\/anticanres.11244","article-title":"Overexpression of PBK\/TOPK contributes to tumor development and poor outcome of esophageal squamous cell carcinoma","volume":"36","author":"Ohashi","year":"2016","journal-title":"Anticancer Res"},{"key":"key20200713185736_b12-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/bjc.2016.394","article-title":"Overexpression of PBK\/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma","volume":"116","author":"Ohashi","year":"2017","journal-title":"Br J Cancer"},{"key":"key20200713185736_b13-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ijms17071007","article-title":"PBK\/TOPK expression predicts prognosis in oral cancer","volume":"17","author":"Chang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20200713185736_b14-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"key20200713185736_b15-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jmb.2007.04.067","article-title":"A mitotic kinase TOPK enhances Cdk1\/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis","volume":"370","author":"Abe","year":"2007","journal-title":"J Mol Biol"},{"key":"key20200713185736_b16-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1349-7006.2009.01400.x","article-title":"Critical roles of T-LAK cell-originated protein kinase in cytokinesis","volume":"101","author":"Park","year":"2010","journal-title":"Cancer Sci"},{"key":"key20200713185736_b17-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1126\/science.283.5410.2089","article-title":"Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A","volume":"283","author":"Seeling","year":"1999","journal-title":"Science"},{"key":"key20200713185736_b18-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"key20200713185736_b19-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood.V83.1.217.217","article-title":"Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias","volume":"83","author":"Miki","year":"1994","journal-title":"Blood"},{"key":"key20200713185736_b20-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V78.7.1789.1789","article-title":"Establishment of an interleukin-3-dependent leukemic cell line from a patient with chronic lymphocytic leukemia in the acute phase","volume":"78","author":"Tohda","year":"1991","journal-title":"Blood"},{"key":"key20200713185736_b21-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0145-2126(98)00172-6","article-title":"Establishment of a double Philadelphia chromosome-positive acute lymphoblastic leukemia-derived cell line, TMD5: Effects of cytokines and differentiation inducers on growth of the cells","volume":"23","author":"Tohda","year":"1999","journal-title":"Leuk Res"},{"key":"key20200713185736_b22-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.2910340213","article-title":"Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus","volume":"34","author":"Sugamura","year":"1984","journal-title":"Int J Cancer"},{"key":"key20200713185736_b23-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1099\/jgv.0.000733","article-title":"A novel mother-to-child human T-cell leukaemia virus type-1 (HTLV-1) transmission model for investigating the role of maternal anti-HTLV-1 antibodies using orally infected mother rats","volume":"98","author":"Murakami","year":"2017","journal-title":"J Gen Virol"},{"key":"key20200713185736_b24-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood.V91.10.3927.3927_3927_3934","article-title":"Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR\/ABL expression","volume":"91","author":"Klucher","year":"1998","journal-title":"Blood"},{"key":"key20200713185736_b25-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/sj.onc.1210117","article-title":"Rottlerin synergistically enhances imatinib-induced apoptosis of BCR\/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta","volume":"26","author":"Kurosu","year":"2007","journal-title":"Oncogene"},{"key":"key20200713185736_b26-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-08-2978","article-title":"Sorafenib induces apoptosis specifically in cells expressing BCR\/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway","volume":"69","author":"Kurosu","year":"2009","journal-title":"Cancer Res"},{"key":"key20200713185736_b27-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: An efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther"},{"key":"key20200713185736_b28-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185736_b29-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1074\/mcp.M114.042812","article-title":"Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation","volume":"14","author":"Bassani-Sternberg","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"key20200713185736_b30-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1074\/mcp.M500076-MCP200","article-title":"Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS\/MS","volume":"4","author":"Hofmann","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"key20200713185736_b31-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"key20200713185736_b32-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1074\/mcp.R300013-MCP200","article-title":"Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response","volume":"3","author":"Purcell","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"key20200713185736_b33-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"M111.010587","DOI":"10.1074\/mcp.M111.010587","article-title":"PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"key20200713185736_b34-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1128\/JVI.01464-10","article-title":"Novel immunodominant peptide presentation strategy: A featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J Virol"},{"key":"key20200713185736_b35-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nature21433","article-title":"Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens","volume":"543","author":"Khodadoust","year":"2017","journal-title":"Nature"},{"key":"key20200713185736_b36-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1523\/JNEUROSCI.3207-05.2005","article-title":"PBK\/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase","volume":"25","author":"Dougherty","year":"2005","journal-title":"J Neurosci"},{"key":"key20200713185736_b37-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1016\/S0021-9258(17)39148-2","article-title":"Equilibrium and rapid kinetic studies on nocodazole-tubulin interaction","volume":"260","author":"Head","year":"1985","journal-title":"J Biol Chem"},{"key":"key20200713185736_b38-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"259ra145","DOI":"10.1126\/scitranslmed.3010277","article-title":"TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis","volume":"6","author":"Matsuo","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20200713185736_b39-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"47195","DOI":"10.18632\/oncotarget.17587","article-title":"PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of \u03b2-Catenin signaling in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185736_b40-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/jcb.26052","article-title":"FOXM1 transcription factor: A new component of chronic myeloid leukemia stem cell proliferation advantage","volume":"118","author":"Mancini","year":"2017","journal-title":"J Cell Biochem"},{"key":"key20200713185736_b41-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1021\/cb700021z","article-title":"The 3D structure of protein phosphatase 2A: New insights into a ubiquitous regulator of cell signaling","volume":"2","author":"Mumby","year":"2007","journal-title":"ACS Chem Biol"},{"key":"key20200713185736_b42-ijo-54-05-1785","first-page":"1","article-title":"Protein phosphatase 2A regulatory subunits and cancer","volume":"1795","author":"Eichhorn","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20200713185736_b43-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molcel.2011.02.007","article-title":"Clk2 and B56\u03b2 mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt","volume":"41","author":"Rodgers","year":"2011","journal-title":"Mol Cell"},{"key":"key20200713185736_b44-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","article-title":"AKT signaling in normal and malignant cells","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"key20200713185736_b45-ijo-54-05-1785","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.2008.19.8853","article-title":"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR\/ABL mutants","volume":"27","author":"Redaelli","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:29:10Z","timestamp":1663028950000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4740","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]}}}